Discover 1,424 paid clinical trials in Clearwater, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,424
RCT of the Jewish Family & Children's Services (JFCS) HFHC Program
for
Family Relations
Location: Sarasota FL
Sponsor: Jewish Family & Children's Service of the Suncoast, Inc.
Sex: All
Age: 18 - 64
Code: NCT02853825
Recruiting
A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer
for
Platinum-resistant Ovarian Cancer
Location: Sarasota FL, Fairfax VA, Springdale AR, Detroit MI,
Sponsor: Stemline Therapeutics, Inc.
Sex: Female
Age: 18+
Code: NCT07226427
Phase 1, Recruiting
Study of ACR-2316 in Specific Advanced Solid Tumors
for
Specific Advanced Solid Tumors
Location: Sarasota FL, Huntersville NC, Franklin TN, Houston TX,
Sponsor: Acrivon Therapeutics
Sex: All
Age: 18+
Code: NCT06667141
Phase 1, Phase 2, Recruiting
A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
for
Colorectal Cancer, Non-Small Cell Lung Cancer, Breast Cancer,
Location: Sarasota FL, Houston TX, Irving TX, New Haven CT,
Sponsor: Immunome, Inc.
Sex: All
Age: 18+
Code: NCT07578571
Phase 1, Recruiting
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
for
Heart Failure
Location: Bradenton FL, Miramar FL, Fort Lauderdale FL,
Sponsor: Colorado Prevention Center
Sex: All
Age: 18+
Code: NCT06024746
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
for
Chronic Inflammatory Demyelinating Polyneuropathy
Location: Bradenton FL, Orlando FL, Homewood AL, New Orleans LA,
Sponsor: Sanofi
Sex: All
Age: 18+
Code: NCT06290141
Phase 3, Recruiting
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
for
Metabolic Dysfunction-associated Steatohepatitis
Location: Bradenton FL, Ocala FL, Viera FL, Port Orange FL,
Sponsor: Eccogene
Sex: All
Age: 18 - 70+
Code: NCT07288138
Phase 2, Recruiting
To Investigate the Efficacy of Treatment With Oral NA-921 (Bionetide) Versus Placebo in Females With Rett Syndrome
for
Rett Syndrome
Location: Tampa FL, Houston TX, Baltimore MD, Chicago IL,
Sponsor: Biomed Industries, Inc.
Sex: Female
Age: 5 - 20
Code: NCT06840496
Phase 3, Recruiting
An Efficacy and Safety Study of Cenegermin Ophthalmic Solution Compared With Vehicle in the Treatment of PCED
for
Persistent Corneal Epithelial Defect
Location: Tampa FL, Jacksonville FL, Miami FL, Durham NC,
Sponsor: Dompé Farmaceutici S.p.A
Sex: All
Age: 18+
Code: NCT07519902
Phase 3, Recruiting
Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
for
Multiple Sclerosis
Location: Tampa FL, Orlando FL, Altamonte Springs FL,
Sponsor: Sanofi
Sex: All
Age: 18 - 60
Code: NCT07325292
Phase 3, Recruiting
A Phase 2a Study of SUN-627 in Participants With Non-Active Secondary Progressive and Primary Progressive Multiple Sclerosis (SPMS/PPMS)
Location: Tampa FL, Orlando FL, Atlanta GA, Ridgeland MS,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT06649110
Phase 1, Phase 2, Recruiting
A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
for
Focal Segmental Glomerulosclerosis,
Location: Tampa FL, Atlanta GA, Birmingham AL, Chapel Hill NC,
Sponsor: Sanofi
Sex: All
Age: 16 - 70+
Code: NCT06500702
Phase 2, Recruiting
An Open-label Trial of Intravenous Immune Globulin (IVIG)in Treating Spinocerebellar Ataxias
for
Spinocerebellar Ataxias
Location: Tampa FL
Sponsor: University of South Florida
Sex: All
Age: 18 - 70+
Code: NCT02287064
Phase 1, Recruiting
Neurophysiological Mechanisms of Accelerated Resolution Therapy (ART)
for
Depressive Symptoms, Stress Disorder, Acute,
Location: Tampa FL
Sponsor: University of South Florida
Sex: All
Age: 18+
Code: NCT04121884
Recruiting
Safety and Efficacy Study of Magnetic Fields to Treat Alzheimer's Disease